Schedule 13D ownership disclosure

NEOLEUKIN THERAPEUTICS INC

Security class unavailable · CUSIP: 64049K104

Event date: 2019-12-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,802,740
Percent of class
9.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-075093
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Dec 20, 2019
Reporting period
Dec 17, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub